EligibleTrials

Clinical trials recruiting for Microsatellite Stable Colorectal Cancer

3
Recruiting trials
22
US states with sites
8
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 3Phase 2 2

Drugs and treatments being studied

InterventionTrials
Atezolizumab1
BMS-936558-011
BMS-9863401
Bevacizumab1
Docetaxel1
FOG-0011
Nivolumab1
Pumitamig1
Trifluridine/tipiracil1
VET3-TGI1
mFOLFOX-61

Where trials are recruiting (top US states)

StateRecruiting trials
California3
Texas3
Florida2
New York2
Oregon2
Pennsylvania2
Tennessee2
Arizona1
Colorado1
Connecticut1
District of Columbia1
Indiana1

Top cities

Houston, Texas 3Los Angeles, California 3Nashville, Tennessee 2New York, New York 2Pittsburgh, Pennsylvania 2Portland, Oregon 2Aurora, Colorado 1Baltimore, Maryland 1Boston, Massachusetts 1Charlottesville, Virginia 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Microsatellite Stable Colorectal Cancer often also study these conditions. Each links to its own recruiting-trial list.

Non-small cell lung cancer 507Melanoma 487Lung cancer 2180Colorectal cancer 1359Cervical cancer 71Urothelial Carcinoma 29Triple Negative Breast Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Squamous Cell Carcinoma 14Solid Tumor, Adult 38

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Microsatellite Stable Colorectal Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.